Aktiia, a blood pressure monitoring wearable developer, has successfully raised CHF 27 million (USD 30 million) in a funding round led by Redalpine, with participation from Khosla Ventures, Molten, Translink Capital, Verve, and 415 Capital. In addition, the company appointed Daniel Graf as its new president and board member.
The new funds will be allocated toward advancing the company’s AI-driven blood pressure management technology to address hypertension management. As of February 2024, Aktiia's device has gained over 60,000 customers globally and medical approval in 44 countries.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.